Results 11 to 20 of about 2,769,816 (316)

Liver [PDF]

open access: yesModern Pathology, 2016
The median waiting time for patients with MELD ≥ 35 decreased from 18 days in 2012 to 9 days in 2014, after implementation of the Share 35 policy in June 2013. Similarly, mortality among candidates listed with MELD ≥ 35 decreased from 366 per 100 waitlist years in 2012 to 315 in 2014.
W R, Kim   +10 more
  +9 more sources

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes [PDF]

open access: yes, 2023
Background/aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is categorized into three subtypes: overweight/obese (OW), lean/normal weight with metabolic abnormalities, and diabetes mellitus (DM).
임태섭, 김승업, 김자경
core   +1 more source

The liver [PDF]

open access: yesCurrent Biology, 2017
The liver is a critical hub for numerous physiological processes. These include macronutrient metabolism, blood volume regulation, immune system support, endocrine control of growth signaling pathways, lipid and cholesterol homeostasis, and the breakdown of xenobiotic compounds, including many current drugs.
Elijah, Trefts   +2 more
openaire   +2 more sources

Risk factors for alcohol recidivism after liver transplantation [PDF]

open access: yes, 2021
Go to Background: Alcoholic liver disease (ALD) has been increasing recently and the second most common indication for liver transplantation (LT) in Korea.
이재근   +8 more
core   +1 more source

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease [PDF]

open access: yes, 2022
Background/aims: Metabolic dysfunction associated fatty liver disease (MAFLD) has recently been introduced to compensate for the conventional concept of nonalcoholic fatty liver disease (NAFLD).
차봉수   +10 more
core   +1 more source

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis [PDF]

open access: yes, 2023
Background/aims: There are no data regarding the association between sarcopenic obesity status and nonalcoholic fatty liver disease (NAFLD) and NAFLD-associated liver fibrosis.
박종숙   +4 more
core   +1 more source

Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. [PDF]

open access: yes, 2011
This review summarizes the document elaborated by the Italian Association for the Study of the Liver (AISF) ad hoc committee "Vascular disorders of the liver" on the primary circulatory liver diseases, which include Budd-Chiari syndrome, obstruction of ...
Riggio O   +5 more
core   +1 more source

Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. [PDF]

open access: yes, 2007
Contains fulltext : 51690.pdf (Publisher’s version ) (Closed access)BACKGROUND: Liver failure following liver surgery is caused by an insufficient functioning remnant cell mass.
Derikx, J.P.M.   +15 more
core   +1 more source

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease [PDF]

open access: yes, 2022
Background/aims: : Nonalcoholic fatty liver disease (NAFLD) and obesity are independently associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality in patients with NAFLD. Many NAFLD patients are
차봉수   +12 more
core   +1 more source

Liver Anatomy: Microcirculation of the Liver [PDF]

open access: yesSeminars in Interventional Radiology, 2008
Comprehension of the structural and functional characteristics of the hepatic microcirculation can help improve the design, planning, and practice of imaging-guided treatment for hepatic tumors and for portal vein embolization (PVE). The hepatic microcirculation derives dual blood supply from the portal vein and the hepatic artery.
Zuxing, Kan, David C, Madoff
openaire   +2 more sources

Home - About - Disclaimer - Privacy